Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 5
Review
Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,222 | Dovepress* | 6,970+ | 1,782 | 8,752 | |
| PubMed Central* | 252 | 69 | 321 | ||
| Totals | 7,222 | 1,851 | 9,073 | ||
|
*Since 1 September 2014 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar